Talis Biomedical Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$5.91 | -$5.91 | -$5.91 |
| Q2 2024 | 1 | -$5.06 | -$5.06 | -$5.06 |
| Q3 2024 | 1 | -$5.79 | -$5.79 | -$5.79 |
| Q1 2025 | 1 | -$6.99 | -$6.99 | -$6.99 |
| Q2 2025 | 1 | -$7.03 | -$7.03 | -$7.03 |
| Q3 2025 | 1 | -$7.33 | -$7.33 | -$7.33 |
| Q4 2025 | 1 | -$6.43 | -$6.43 | -$6.43 |
Talis Biomedical Corporation Earnings Date And Information
Talis Biomedical Corporation last posted its earnings results on Thursday, August 10th, 2023. The company reported $-8.27 earnings per share for the quarter, missing analysts' consensus estimates of $-0.73 by $7.54. The company had revenue of 0 for the quarter and had revenue of 412,000 for the year. Talis Biomedical Corporation has generated $-34 earnings per share over the last year ($-34.12 diluted earnings per share) and currently has a price-to-earnings ratio of -0.06. Talis Biomedical Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based on prior year's report dates.
Talis Biomedical Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/19/2024 | Q2 2024 | -$4.86 | $0 | $0 | ||
| 05/08/2024 | Q1 2024 | -$7.15 | $73,000 | |||
| 03/28/2024 | Q4 2023 | -$7.40 | $151,000 | |||
| 09/29/2023 | Q3 2023 | -$8.62 | $105,000 | $76,000 | ||
| 08/10/2023 | Q2 2023 | -$0.73 | -$8.27 | -7.54 | $105,000 | $48,000 |
| 05/11/2023 | Q1 2023 | -$11.09 | -$9.32 | 1.77 | $137,000 | |
| 03/22/2023 | Q4 2022 | -$11.39 | $19.31 | 30.7 | $107,000 | |
| 11/03/2022 | Q3 2022 | -$11.09 | -$14.22 | -3.13 | $360,000 | $730,000 |
| 08/02/2022 | Q2 2022 | -$12.29 | -$15.07 | -2.78 | $1.20 M | $502,000 |
| 05/10/2022 | Q1 2022 | -$17.09 | -$18.78 | -1.69 | $2.31 M | |
| 03/15/2022 | Q4 2021 | -$1.28 | -$16.28 | -15 | $-218 | |
| 11/15/2021 | Q3 2021 | -$22.35 | $1.46 M | $218 | ||
| 08/10/2021 | Q2 2021 | -$13.04 | -$37.71 | -24.67 | $0 | |
| 05/13/2021 | Q1 2021 | -$69.21 | $0 | |||
| 03/30/2021 | Q4 2020 | -$0.78 | -$33.69 | -32.91 | $10,938 | |
| 09/29/2020 | Q3 2020 | -$101.53 | $0 | |||
| 06/29/2020 | Q2 2020 | -$34.56 | $0 | |||
| 03/30/2020 | Q1 2020 | -$25.37 | $0 | |||
| 12/30/2019 | Q4 2019 | -$26.27 | $1.51 M |
Talis Biomedical Corporation Earnings: Frequently Asked Questions
-
When is Talis Biomedical Corporation's earnings date?
Talis Biomedical Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.
-
How can I listen to Talis Biomedical Corporation's earnings conference call?
The conference call for Talis Biomedical Corporation's latest earnings report can be listened to online.
-
How can I read Talis Biomedical Corporation's conference call transcript?
The conference call transcript for Talis Biomedical Corporation's latest earnings report can be read online.
-
How much revenue does Talis Biomedical Corporation generate each year?
Talis Biomedical Corporation (:TLIS) has a recorded annual revenue of $412,000.
-
How much profit does Talis Biomedical Corporation generate each year?
Talis Biomedical Corporation (:TLIS) has a recorded net income of $412,000. Talis Biomedical Corporation has generated $-34.12 earnings per share over the last four quarters.
-
What is Talis Biomedical Corporation's price-to-earnings ratio?
Talis Biomedical Corporation (:TLIS) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.01.
